Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × Cardiovascular Diseases × Chocolate × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Nutrition Related Cancer 1 Neoplasms 1 Cardiovascular Diseases 1

Interventions

Aspirin 4 Vitamin E 2 Metformin 2 Geritol 2 Diet, Mediterranean 2 Cholecalciferol 2 Blood Pressure 2 phosphoribosylformylglycinamidine synthetase 1 glycidol 1 ficlatuzumab 1 beta Carotene 1 acetyl-2-naphthylalanyl-3-chlorophenylalanyl-1-oxohexadecyl-seryl-4-aminophenylalanyl(hydroorotyl)-4-aminophenylalanyl(carbamoyl)-leucyl-ILys-prolyl-alaninamide 1 Vorinostat 1 Vitamin D 1 Vascular Stiffness 1 Tumor Necrosis Factor Inhibitors 1 Therapeutics 1 Sugars 1 Spironolactone 1 Raloxifene Hydrochloride 1 Pulse Wave Analysis 1 Omeprazole 1 Nutrition Assessment 1 Noninvasive Prenatal Testing 1 Naproxen 1 Lysine Acetyltransferase 5 1 Liraglutide 1 Linseed Oil 1 High-Intensity Interval Training 1 Heart Rate 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02422745 2025-09-24

COSMOS

Brigham and Women's Hospital

Phase 4 Completed

21,442 enrolled 31 charts

Cardiovascular Diseases, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡